Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04971694 · ClinicalTrials.gov registry record
Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 175
- Enrollment target
NCT04971694: Completed study, sponsored by Pediatrix.
NCT04971694 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04971694 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
Assess the impact of steroid, diuretic, and fluid practices on BPD outcomes in extreme premature infants in the Banner - University Medical Center Phoenix (BUMCP) neonatal intensive care unit (NICU).
Primary Outcome
\- The incidence of BPD stratified into three stages based on the type of support required at 36 weeks CGA
Interventions
- OTHER No interventions or procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2024-07-06 |
What the finished NCT04971694 record still lists
NCT04971694 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No interventions or procedures is the first listed.
NCT04971694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04971694 about?
NCT04971694 is a clinical study titled "Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes". Assess the impact of steroid, diuretic, and fluid practices on BPD outcomes in extreme premature infants in the Banner - University Medical Center Phoenix (BUMCP) neonatal intensive care unit (NICU).
What is the current status of trial NCT04971694?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2021-08-30. Estimated completion is 2024-07-06.
What interventions are being tested in trial NCT04971694?
The interventions under investigation include: No interventions or procedures (OTHER).
Who is sponsoring clinical trial NCT04971694?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI